gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · ANGOHealthcareSurgical Instruments

AngioDynamics, Inc. (ANGO)

$12.25+4.43%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$11.73▼ 0.85% in range
Nov 3, 2025Low $9.70 · High $16.13Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

AngioDynamics closed at $12.25 on Nov 4, up 4.43%, 24.1% below its 52-week closing high. Volume of 869.4K shares was 0.84× its 20-day average (close to normal).

Split-adjusted performance: -15.0% over one month, +10.9% over six months, +3.6% over one year.

In the quarter ended Aug 31, 2026, revenue was $80.92M, up 6.9% from a year earlier, with a net margin of -8.8%.

Short interest was 1.9M shares at the Oct 15 settlement, up 48.1% from the prior report (5.2% of float, 1.5 days to cover).

Market cap$515.2M42.1M shares
Revenue · quarter$80.9M+6.9% YoY
Diluted EPS$-0.17—
P/E · TTM—P/S 1.6×
Net margin-8.8%Gross 59.4%
Dividend yieldNone
52-week range9.70 – 16.13−24.1% from high
Volume869.4K0.84× 20-day avg
Volatility · 60d57.0%Annualised
Short % of float5.2%1.5 days to cover
Net cash$34.0MCash $34.0M
Next earnings—Not scheduled
Split-adjusted performance
1W +1.0%1M −15.0%3M −18.9%6M +10.9%YTD −4.6%1Y +3.6%3Y +93.2%5Y −56.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum63
Revenue growth45
Net margin47
Value (low P/E)—
Size62

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short1.9M+48.1% vs prior
Days to cover1.5Settled Oct 15
% of float5.2%
Short vol. 10d48.4%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ANGOAngioDynamics$12.25+4.43%+10.9%+6.9%−8.8%—$515.2M
DCTHDelcath Systems$14.82+2.92%+31.6%+20.6%9.2%966.6$514.2MCompare
RCELAvita Medical$16.32+6.46%+269.2%+17.8%−35.3%—$504.7MCompare
SGHTSight Sciences$9.68+2.76%+125.1%+19.5%−19.0%—$533.3MCompare
CERSCerus$2.42+3.21%−6.8%+6.3%−0.9%—$486.7MCompare
MDXGMiMedx Group$3.20−1.54%−12.6%−45.2%−13.9%—$467.0MCompare
NPCENeuropace$13.34+8.37%−26.4%+17.1%−27.2%—$457.9MCompare
SSIISS Innovations International$2.27−2.58%−44.2%+39.4%−19.1%—$455.1MCompare
CARLCarlsmed$16.09+11.74%+63.5%—−55.5%—$439.3MCompare

News about AngioDynamics

All news →
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/YZacks Investment Research · Oct 9, 2026NeutralAngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research · Oct 8, 2026Neutral

Quick answers

What does AngioDynamics do?
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance.
What is ANGO's market cap?
$515.17M, based on the Nov 4 close of $12.25.
Does AngioDynamics pay a dividend?
No regular cash dividend has been paid in the last year.
How much of ANGO is sold short?
1.9M shares, 5.2% of float, as of Oct 15, 2026.
What sector is ANGO in?
Healthcare, in the Surgical Instruments industry.

About AngioDynamics

AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.

HQ: Latham, NY632 employeesListed May 27, 2004angiodynamics.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology